Cargando…
Advanced medullary thyroid cancer: pathophysiology and management
Medullary thyroid carcinoma (MTC) is a rare malignant tumor originating from thyroid parafollicular C cells. This tumor accounts for 3%–4% of thyroid gland neoplasias. MTC may occur sporadically or be inherited. Hereditary MTC appears as part of the multiple endocrine neoplasia syndrome type 2A or 2...
Autores principales: | Ferreira, Carla Vaz, Siqueira, Débora Rodrigues, Ceolin, Lucieli, Maia, Ana Luiza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658436/ https://www.ncbi.nlm.nih.gov/pubmed/23696715 http://dx.doi.org/10.2147/CMAR.S33105 |
Ejemplares similares
-
Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
por: Ceolin, Lucieli, et al.
Publicado: (2011) -
Effect of 3′UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma
por: Ceolin, Lucieli, et al.
Publicado: (2016) -
Role of VEGF-A and Its Receptors in Sporadic and MEN2-Associated Pheochromocytoma
por: Ferreira, Carla Vaz, et al.
Publicado: (2014) -
The BRAF(V600E) mutation analysis and risk stratification in papillary thyroid carcinoma
por: Scheffel, Rafael Selbach, et al.
Publicado: (2020) -
Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)